BioVersys AG

Fr 22.40As of Sun 8 Nov 2026, 12:00 UTC
SWX:BIOVHealthcare
Country Switzerland
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE (46.05%)
Biotechnology
Beta (5Y) —
PE TTM —
TSR TTM (6.67%)
Mkt cap Fr 131.4M
ROIC (20.27%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
Fr 26
16.44%
(72.40%)
Hold 8|2|4|1|4
4Q25
1Q26
2Q26
3Q26
Earnings per shareFr
0.24
0.23
0.23
0.23
21.29%
18.79%
11.86%
7.10%
RevenueFr M
8.439
8.682
8.431
8.451
2.02%
5.75%
1.60%
4.41%
Peers (US$161.1M)
Cap (US$)
PE
221.7M
—
Capital
TTM
5Y
10Y
Leveragex
0.483
0.267
0.199
EBIT/Intx
3.292
0.181
0.176
Own earn%
(46.70)
(168.83)
(130.09)
Sh yield%
15.21
20.87
23.41
Owners
Insiders/Inst%
8.38
59.43
Short interest%
4.18
SBC / revenue%
4.49
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
5
Op margin range%
12–20
$1 testx
0.2
Incr. ROIC%
8